U.S. Entertainment Stock News

KBR (KBR) is back in focus after a run of sizeable U.S. government wins, including a $449 million Army LOGCAP V extension, a $510 million analytics contract, and fresh Air Force AFCAP V task orders. See our latest analysis for KBR. Despite a series of sizeable government contract wins and reaffirmed guidance, sentiment around KBR has softened, with a 30-day share price return of -12.05% and a 1-year total shareholder return of -38.54% pointing to fading momentum after a tougher few years. If...

monday.com (MNDY) has reintroduced itself as an AI Work Platform, centering its offer on built in AI agents that automate workflows across departments and connect with tools like Anthropic’s Claude and Microsoft 365 Copilot. See our latest analysis for monday.com. The AI Work Platform launch and the upcoming earnings report have arrived after a weak stretch for the stock, with a 90 day share price return of 22.05% decline and a 1 year total shareholder return of 72.88% decline. However,...

Inovio Pharmaceuticals recently announced plans to release its Q1 2026 earnings after market close on May 13, 2026, alongside a conference call and upcoming scientific presentations on its DNA medicine pipeline for HPV-related diseases, cancer, and infectious diseases. Investor attention has intensified as Inovio’s DNA vaccine and gene transfer programs gain visibility, supported by significant institutional ownership and new clinical data disclosures on candidates such as INO-3107 and its...

Recent Stock Performance Snapshot ZTO Express (Cayman) (ZTO) has drawn investor attention after a recent pullback, with the stock down 2.2% over the past day and 1.1% over the past week, despite positive longer term returns. Over the past month the stock shows a 2.1% gain, while the past 3 months and year to date performance stand at 5.1% and 18.0% respectively. The 1 year total return is 37.7%, although 3 year and 5 year total returns are modestly negative. See our latest analysis for ZTO...

Recent performance snapshot and what it might signal Somnigroup International (SGI) has drawn attention after a period where the stock declined about 10% over the past week and roughly 27% over the past 3 months, despite positive annual revenue and net income growth. See our latest analysis for Somnigroup International. Despite the recent share price pressure, with a 1 day share price return of negative 10.11% and a 90 day share price return of negative 26.63%, Somnigroup International still...

Kestrel Group (KG) has wrapped up FY 2025 with fourth quarter revenue of US$10.2 million and a basic EPS loss of US$2.13, alongside net income from ongoing operations of a US$16.5 million loss and a US$1.4 million loss from discontinued operations. Over recent periods the company has seen quarterly revenue move from US$1.22 million in Q4 2024 to US$17.4 million in Q3 2025 and then US$10.2 million in Q4 2025. Basic EPS shifted from a small profit of US$0.02 in Q4 2024 to a sizeable profit of...

Why Patria Investments (PAX) is on investors’ radar today Patria Investments (PAX) has drawn attention after recent trading left the stock around $12.04, with returns showing mixed signals over the past week, month and past 3 months. See our latest analysis for Patria Investments. The recent 6.8% one day share price decline and 24.4% year to date share price loss contrast with a 9.8% one year total shareholder return. This suggests that recent momentum has faded even as income and past...

In early May 2026, IonQ reported first-quarter 2026 results showing sales of US$64.67 million versus US$7.57 million a year earlier and net income of US$805.36 million, while also advancing its quantum offering through new contracts, quantum networking projects, and the commercial launch of a millimeter-precision InSAR Earth-monitoring product. These developments underscore IonQ’s shift from primarily research-focused roots toward a broader commercial platform spanning quantum computing,...

C.H. Robinson Worldwide (CHRW) shares came under pressure after Amazon said it would open its supply chain services to outside businesses, while a pending Supreme Court case on freight broker liability added another layer of concern. See our latest analysis for C.H. Robinson Worldwide. At a share price of $171.37, C.H. Robinson’s recent 7 day share price return of 5.74% decline and 90 day share price return of 14.57% decline point to fading momentum as investors weigh Amazon’s competitive...

TG Therapeutics (TGTX) drew fresh attention after record-setting Q1 2026 revenue tied to BRIUMVI, a higher full year revenue outlook of about US$925 million, and progress on key Phase 3 clinical milestones. See our latest analysis for TG Therapeutics. The recent six day rally, with a 7 day share price return of 27.37% and a 90 day share price return of 49.08%, suggests momentum has strengthened around Q1 results, raised 2026 guidance and upcoming BRIUMVI Phase 3 readouts. The 1 year total...

GitLab (GTLB) has drawn fresh attention after expanding its integration with Anthropic’s Claude models, incorporating advanced AI agents into its existing DevSecOps governance, compliance, and audit framework for enterprise software development workflows. See our latest analysis for GitLab. At a share price of $25.92, GitLab has seen a 6.71% 1 day and 17.07% 7 day share price return. However, its year to date share price return of 28.36% and 1 year total shareholder return of 47.67% indicate...

In late April 2026, Roblox Corporation reported first-quarter sales of US$1,442 million versus US$1,035 million a year earlier, alongside a wider net loss of US$246 million and higher per-share losses. At the same time, Roblox cut its full-year outlook as new child safety and age-verification measures disrupted user engagement, even as it appointed Sunil Rao to lead expansion in India, one of its fastest-growing markets. Now we’ll examine how lowered guidance tied to friction from new...

Why Medical Properties Trust’s Latest Earnings Matter for Investors Medical Properties Trust (MPT) returned to profitability in the first quarter of 2026, reporting US$252.07 million in revenue and net income of US$32.83 million, after a net loss in the same period last year. See our latest analysis for Medical Properties Trust. The stronger first quarter numbers and return to profitability appear to have supported a short term rebound, with a 7 day share price return of 7.89% and 30 day...

Blue Owl Capital (OWL) is back in focus after its first quarter update, which combined higher revenue and net income with a raised quarterly dividend, active share repurchases, and a realized gain from a partial SpaceX stake sale. See our latest analysis for Blue Owl Capital. Despite the stronger first quarter update and active capital returns, Blue Owl Capital’s recent share price performance has been mixed. A 22.2% 30 day share price return contrasts with a 32.4% share price decline year to...

In the past week, Valvoline Inc. reported second-quarter 2026 results showing sales rising to US$503.8 million from US$403.2 million a year earlier, with net income increasing to US$44.8 million from US$37.6 million and earnings per share improving to US$0.35 from US$0.29. The company also raised its fiscal 2026 same-store sales guidance and highlighted better-than-expected contributions from the Breeze Auto Care integration, while committing US$750,000 over three years to support mental...

Korn Ferry (NYSE:KFY) has been named America’s Best Executive Recruiter by Forbes Magazine for the ninth time in ten years. The recognition highlights Korn Ferry’s position among the top professional search firms in the United States. Korn Ferry’s latest recognition comes as the stock trades at $67.14, with a 3.8% return over the past year and a 51.2% return over three years. The company’s track record in executive recruitment, reflected in this recurring award, helps frame NYSE:KFY as a...

Lucid Group, Inc. reported first-quarter 2026 results showing sales of US$282.47 million versus US$235.05 million a year earlier, alongside a net loss of US$1.03 billion and a basic loss per share of US$3.46, both wider than the prior year. Despite ramping production and securing expanded backing from partners such as Uber and the Saudi Arabian government, Lucid’s suspended guidance, quality issues, and investigations into business practices have increased uncertainty around its operational...

Crocs, Inc. recently reported first-quarter 2026 results, with sales of US$921.46 million and net income of US$137.56 million, while also issuing guidance that full-year 2026 revenues could range from a 1% decline to a 1% increase versus 2025 and GAAP diluted EPS of US$12.01 to US$12.56. Despite lower year-on-year quarterly revenue and earnings, Crocs raised its full-year outlook, indicating management’s confidence while it also invests behind the Hey Dude brand’s new standalone retail...

Caterpillar’s first-quarter 2026 results showed revenue rising to US$17,415 million and net income to US$2,549 million, alongside low double-digit full-year sales guidance, ongoing share repurchases, and new power-generation agreements linked to long-term data center and industrial demand. At the same time, a shareholder proposal on written consents and Caterpillar’s opposition to it highlight an active governance debate unfolding as the company deepens its role in powering AI-related data...

Kennametal Inc. recently reported its fiscal 2026 third-quarter results, with sales rising to US$592.59 million and net income reaching US$58.23 million, while also raising full-year sales guidance to a range of US$2.33 billion to US$2.35 billion. Alongside the stronger earnings and upgraded outlook, the company affirmed a quarterly dividend of US$0.20 per share, highlighting management’s confidence in cash generation and balance sheet flexibility. We’ll now examine how Kennametal’s raised...

In early May 2026, TransDigm Group reported past second-quarter 2026 results showing higher sales and net income year over year, completed an approximately US$798.83 million share repurchase tranche, and finished a broader buyback program totaling about US$2.32 billion for 4.75% of its shares. The company also raised its full-year 2026 guidance for net sales and earnings per share while projecting lower net income than fiscal 2025 due mainly to higher interest costs from recent...

Celcuity's lead drug candidate, gedatolisib, produced positive Phase 3 results in the VIKTORIA-1 trial for PIK3CA-mutant HR+/HER2- metastatic breast cancer. The trial met its primary endpoint and showed a significant improvement in progression-free survival. Celcuity plans to submit a supplemental NDA to the FDA, with full data scheduled for presentation at ASCO 2026. The program follows an existing Priority Review for gedatolisib in the wild-type population, with an FDA decision...

Wondering whether Mattel at around US$15.00 is starting to look like value, or if the stock still has more to prove before it deserves a spot in your portfolio. The share price has moved about 0.5% lower over the last 7 days, after a 4.0% gain over the last 30 days, and is currently sitting on a 25.1% decline year to date and a 13.1% decline over the last year. These moves come as investors weigh up the latest developments around the business and its position in the wider toy and...

Alamo Group Inc. has released its first-quarter 2026 results, reporting sales and revenue of US$417.15 million, up from US$390.95 million a year earlier, while net income eased to US$29.18 million and diluted earnings per share from continuing operations slipped to US$2.41. The combination of higher sales but lower earnings highlights pressure on profitability, offering fresh context for how efficiently Alamo Group is converting growing demand into bottom-line results. We’ll now examine how...